Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma

QR Code

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Chenhui Cai, Ying Zhang, Xu Hu, Wenhui Hu, Sizhen Yang, Hao Qiu, Tongwei Chu
Format:	article
Langue:	EN
Publié:	Frontiers Media S.A. 2021
Sujets:	CDT1 liver hepatocellular carcinoma prognostic value immune infiltration bioinformatics analysis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/e3485b5c89114f4ea6ea2b75f0fd9e9e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
par: Chenhui Cai, et autres
Publié: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
par: Yumei Fan, et autres
Publié: (2021)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
par: Lin T, et autres
Publié: (2021)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
par: Shuai Li, et autres
Publié: (2021)

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
par: Luo Y, et autres
Publié: (2021)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
par: Shun Liu, et autres
Publié: (2021)

A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
par: Qianqian Wu, et autres
Publié: (2021)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant <i>TP53</i> or Wild-Type <i>CTNNB1</i> Gene
par: Jiunn-Chang Lin, et autres
Publié: (2021)

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
par: Yongbiao Huang, et autres
Publié: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
par: Luo M, et autres
Publié: (2021)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
par: Junyu Huo, et autres
Publié: (2021)

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
par: Yuliang Sun, et autres
Publié: (2021)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
par: Rongqiang Liu, et autres
Publié: (2021)

Carcinoma hepatocelular variedad fibrolamelar metastásico en menores de 20 años: Reporte de 2 casos tratados con intención curativa y revisión de la literatura
par: Butte,Jean M, et autres
Publié: (2009)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
par: Susu Zheng, et autres
Publié: (2021)

The predictive role of preoperative serum glutamate dehydrogenase levels in microvascular invasion and hepatocellular carcinoma prognosis following liver transplantation—a single center retrospective study
par: Jinlong Gong, et autres
Publié: (2021)

THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
par: Sri Budhi Rianawati, et autres
Publié: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
par: L. V. Bolotina
Publié: (2020)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
par: Shuang Liu, et autres
Publié: (2021)

Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
par: Xiangdong Ye, et autres
Publié: (2021)

Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma
par: Xiao-Wei Fu, et autres
Publié: (2021)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
par: Amira Isaac, et autres
Publié: (2021)

A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
par: Jianhua Wu, et autres
Publié: (2021)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
par: Zhijun Li, et autres
Publié: (2021)

Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
par: He Aoxiao, et autres
Publié: (2021)

Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer
par: Jiasui Wang, et autres
Publié: (2021)

The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
par: Hiroaki Takaya, et autres
Publié: (2021)

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
par: Mei J, et autres
Publié: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
par: Luo M, et autres
Publié: (2021)

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
par: Liu X, et autres
Publié: (2021)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
par: Alice R. Owens, et autres
Publié: (2021)

Seminal vesicle mass: An unusual site for metastatic hepatocellular carcinoma after orthotopic liver transplant
par: Diana A. Aponte-Colon, et autres
Publié: (2022)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
par: Yu-Jie Xu, et autres
Publié: (2021)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
par: Hsin-Rou Liang, et autres
Publié: (2021)

Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy
par: Jiamin Zhou, et autres
Publié: (2021)

Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
par: Yi-Ran Li, et autres
Publié: (2021)

Three-Device (3D) Technique for Liver Parenchyma Dissection in Robotic Liver Surgery
par: Aristotelis Perrakis, et autres
Publié: (2021)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
par: Hongsheng Lin, et autres
Publié: (2021)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
par: Tianhao Zhang, et autres
Publié: (2021)

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
par: Danyang Zhou, et autres
Publié: (2021)